Tucker Asset Management’s Anixa Biosciences ANIX Stock Holding History

Tucker Asset Management’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10	Closed	-$23	–	334
2024 Q4	$23	Hold	10	–	–	﹤0.01%	1516
2024 Q3	$32	Hold	10	–	–	﹤0.01%	1423
2024 Q2	$22	Hold	10	–	–	﹤0.01%	1636
2024 Q1	$31	Hold	10	–	–	﹤0.01%	1608
2023 Q4	$39	Hold	10	–	–	﹤0.01%	1424
2023 Q3	$33	Hold	10	–	–	﹤0.01%	1352
2023 Q2	$32	Hold	10	–	–	﹤0.01%	1136
2023 Q1	$43	Hold	10	–	–	﹤0.01%	1148
2022 Q4	$42	Sell	10 -90	-90%	-$433	﹤0.01%	805
2022 Q3	$560	Hold	100	–	–	﹤0.01%	729
2022 Q2	$306	Sell	100 -500	-83%	-$1.58K	﹤0.01%	605
2022 Q1	$1.64K	Buy	+600	New	+$1.76K	﹤0.01%	439

Other funds holding ANIX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MWM

Mission Wealth Management Santa Barbara, California $4.86B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tucker Asset Management's ANIX Position: Q1 2025 in Review

Tucker Asset Management sold out of Anixa Biosciences (ANIX) in Q1 2025, closing a stake of 10 shares — an estimated $23 sold.

Tucker Asset Management first reported a position in ANIX in Q1 2022 and held it in 12 quarters. The position peaked at $1.64K in Q1 2022. 58 funds tracked by Wall St. Rank hold ANIX as of Q1 2025.

Tucker Asset Management reported no remaining Anixa Biosciences position as of Q1 2025 after selling out during the quarter.
Tucker Asset Management sold 10 Anixa Biosciences shares in Q1 2025, an estimated $23.
Tucker Asset Management first reported a position in Anixa Biosciences in Q1 2022 and held it in 12 quarters.
Tucker Asset Management's Anixa Biosciences position peaked at $1.64K in Q1 2022.
58 funds tracked by Wall St. Rank held Anixa Biosciences as of Q1 2025.

Based on Tucker Asset Management's 13F filing for Q1 2025, filed 6 Jan 2026.